POLYPHOR AG Spexis Annual General Meeting 2022
Transparency directive : regulatory news
|
Spexis AG / Key word(s): AGMEGM Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, April 27, 2022 Spexis Annual General Meeting 2022 Spexis AG (SIX: SPEX) today announced that its shareholders approved all proposals of the Board of Directors at the 25th Annual General Meeting (AGM) with a significant majority. In line with the COVID-19 Ordinance 3 of the Swiss Federal Council, shareholders were not allowed to attend the AGM in person. The independent proxy represented 25.6% percent of the company's shares. The members of the Board of Directors, Jeffrey Wager, Kuno Sommer, Bernard Bollag, Daniel Hartmann, Robert Clarke, and Dennis Ausiello, were re-elected for a further year in office. In addition, shareholders confirmed Jeffrey Wager as Chairman of the Board of Directors. The agenda items on compensation for the members of the Board of Directors and the executive management were also approved. Furthermore, the increases to the Company's authorized and conditional share capital were approved. The management report, the consolidated financial statements, and the annual financial statements for 2021 were also approved. "On behalf of the Board of Directors, I would like to thank all of Spexis' shareholders for their trust and support at today's AGM," said Jeffrey Wager, Chairman of the Board of Directors.
About Spexis Additional features: File: Spexis AGM results End of ad hoc announcement |
| Language: | English |
| Company: | Spexis AG |
| Hegenheimermattweg 125 | |
| 4123 Allschwil | |
| Switzerland | |
| Phone: | +41 61 567 1600 |
| Fax: | +41 61 567 1601 |
| E-mail: | info@spexisbio.com |
| Internet: | www.spexisbio.com |
| ISIN: | CH0106213793 |
| Valor: | SPEX |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 1336109 |
| End of Announcement | EQS News Service |
|
|
1336109 27-Apr-2022 CET/CEST